Visual ImpairmentVIPPSTAR_UNITNNCT07703150
Promoting Psychophysical Well-being in Children and Adolescents With Visual Impairment
A study testing Adapted Physical Activity Programme in people with Visual Impairment and Cerebral Visual Impairment, run by Università degli Studi di Trento at 1 site in Italy.
Trial summary
Visual impairment (VI) has significant implications not only for visual functioning, but also for the motor development, psychological well-being, and social participation of children and adolescents. Read more about this study
- Who is it for?
- Ages 10 to 17 years
- Conditions the study is for
- Visual Impairment, Cerebral Visual Impairment, Visual Impairments
- What is being tested?
- Adapted Physical Activity Programme
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 20 participants
- Where
- 1 siteItaly
- Study dates
- 1 Jan 2027to 31 Aug 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 10 to 17 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Aged 10 to 17 years.
- Diagnosis of Visual Impairment (VI), defined as a congenital or acquired impairment of visual functioning that cannot be corrected solely through the use of glasses or contact lenses.
- Ability to participate in the exercise protocol, with adapted instructions or support where necessary.
Who cannot join
- Presence of severe neurological, orthopaedic, or cardiac conditions that contraindicate moderate physical exercise.
- Current pregnancy.
- Conditions preventing the safe use of wearable devices, such as severe skin allergies or incompatible medical devices.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Micol Gemignani, PhD contact
Italy1 site
Department of Psychology and Cognitive Science
Rovereto, Trento, 38068
About this study
Official title: Promoting the Psychophysical Well-Being of Children and Adolescents With Visual Impairment
Visual impairment (VI) has significant implications not only for visual functioning, but also for the motor development, psychological well-being, and social participation of children and adolescents. Despite the fundamental role of physical activity in promoting health, autonomy, and quality of life, young people with VI still participate to a limited extent in structured physical activity programmes, owing to the lack of adapted interventions supported by robust scientific evidence. The European VIPPSTAR project (Horizon Europe 2024), conducted at the University of Trento, aims to address this gap through the development and validation of an integrated system of educational and rehabilitation interventions designed to promote the motor, physiological, and psychosocial competences of children and adolescents with VI.
This study marks the transition from the validation of the exercise battery in a controlled setting, carried out during the first phase of the VIPPSTAR project, to its implementation in participants' everyday environments. The aim is to assess its effectiveness, sustainability, and impact on psychophysical and relational well-being.
Read more
The study has a longitudinal, non-profit experimental design and will involve 20 children and adolescents with VI aged 10-17 years (50% female and 50% male), recruited through lower- and upper-secondary schools in the Autonomous Province of Trento participating in the project.
The intervention programme lasts 12 weeks and is divided into two blocks. During Block 1 (8 weeks), participants will complete the motor exercise battery twice weekly in the school setting, under the supervision of Abilnova educators. Sessions will take place twice a week, last approximately 45-60 minutes, and will be accompanied by fortnightly group meetings with classmates aimed at promoting social inclusion. During Block 2 (4 weeks), participants will perform the exercises at home, with the aim of consolidating the skills acquired and promoting autonomy in carrying out physical activity exercises, while continuing the fortnightly peer sessions at school.
The effectiveness of the programme will be evaluated using a pre-post design (T0-T1), with an intermediate assessment at the end of Block 1 (T0.5). An integrated assessment system will be used, including ComfTech® wearable devices for continuous monitoring of physiological parameters, such as heart rate, respiratory rate, body temperature, SpO₂, and ECG; video systems for the assessment of motor and postural performance; standardised questionnaires assessing quality of life and social participation; and structured observation grids during peer sessions. Data will be transmitted to the AVATAR system, a conversational system developed within the project, which processes physiological and kinematic information in real time. AVATAR does not operate autonomously and does not make medical decisions.
The results will contribute to validating an adapted, sustainable, and transferable exercise battery, laying the foundations for large-scale applications in clinical, educational, and rehabilitation settings, with potentially significant benefits for the quality of life and autonomy of young people with VI.
- Being tested
- Adapted Physical Activity Programme
- Keywords
- Physical Activity, Visual Impairment, Psychophysical Well-being, Physiological Monitoring, Social Inclusion
- Medical subject headings
- Vision Disorders, Blindness, Cortical, Motor Activity, Social Inclusion
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Adapted Physical Activity ProgrammeBehavioural
A 12-week adapted physical activity programme for children and adolescents with VI. During the first 8 weeks, participants will complete two supervised school-based exercise sessions per week, each lasting approximately 45-60 minutes, under the supervision of trained Abilnova educators. Fortnightly peer-group sessions with classmates will also be conducted to promote social inclusion. During the final 4 weeks, participants will perform the exercise programme at home to consolidate acquired motor skills and foster autonomy, while continuing the fortnightly peer sessions at school. The programme includes adapted motor, postural, and physical activity exercises tailored to participants' functional abilities.
| Study group | Role | What they receive |
|---|---|---|
| Adapted Physical Activity Programme | Experimental | VI participants will receive a 12-week adapted physical activity programme. During the first 8 weeks, they will attend two supervised school-based exercise sessions per week (approximately 45-60 minutes each), alongside fortnightly peer-group sessions to promote social inclusion. During the final 4 weeks, participants will perform the exercises at home to consolidate acquired skills and support autonomy, while continuing fortnightly peer sessions at school. Receives: Behavioral: Adapted Physical Activity Programme |
What is being measured
The primary outcome is the main question the study is designed to answer.
Feasibility of the Adapted Physical Activity Programme
Feasibility will be assessed through session completion rates across the school-based and home-based intervention blocks and adherence to planned procedures. Feasibility indicators will be reported as percentages, with higher percentages indicating greater feasibility of the programme.
Measured: Baseline before intervention; after 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.
Acceptability of the Adapted Physical Activity Programme
Acceptability will be assessed through the participant-rated acceptability of the programme using a 5-point Likert scale administered via the AVATAR system. Acceptability scores range from 1 to 5, with higher scores indicating greater acceptability of the programme.
Measured: After 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.
Change in Movement Amplitude
Changes in movement amplitude will be assessed using video-based analysis during the adapted exercise battery. Movement amplitude will be quantified as the range of motion of selected body segments during predefined motor tasks.
Measured: Baseline before intervention; after 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.
Change in Movement Execution Speed
Changes in movement execution speed will be assessed using video-based analysis during the adapted exercise battery. Execution speed will be quantified as the time required to complete predefined motor tasks.
Measured: Baseline before intervention; after 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.
Change in Postural Stability
Changes in postural stability will be assessed using video-based analysis during the adapted exercise battery. Postural stability will be quantified through indicators of balance control during predefined standing and movement tasks.
Measured: Baseline before intervention; after 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.
Change in Heart Rate
Changes in heart rate will be assessed through real-time monitoring with ComfTech® wearable devices. Heart rate will be reported in beats per minute.
Measured: Baseline before intervention; after 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.
Change in Respiratory Rate
Changes in respiratory rate will be assessed through real-time monitoring with ComfTech® wearable devices. Respiratory rate will be reported in breaths per minute.
Measured: Baseline before intervention; after 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.
Change in Peripheral Oxygen Saturation
Changes in peripheral oxygen saturation will be assessed through real-time monitoring with ComfTech® wearable devices. Peripheral oxygen saturation will be reported as the percentage of oxygen-saturated hemoglobin in the blood.
Measured: Baseline before intervention; after 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.
Change in Body Temperature
Changes in body temperature will be assessed through real-time monitoring with ComfTech® wearable devices. Body temperature will be reported in degrees Celsius.
Measured: Baseline before intervention; after 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.
Change in Electrocardiographic Parameters
Changes in electrocardiographic parameters will be assessed through real-time monitoring with ComfTech® wearable devices. Electrocardiographic data will be used to derive cardiac rhythm-related parameters during the adapted exercise battery.
Measured: Baseline before intervention; after 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.
Change in Pediatric Quality of Life
Changes in pediatric quality of life will be assessed using the Pediatric Quality of Life Inventory Version 4.0. Scores range from 0 to 100, with higher scores indicating better health-related quality of life. The questionnaire will be completed using participant self-report and parent proxy-report versions, where applicable.
Measured: Baseline before intervention; after 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.
Change in Vision-Related Quality of Life
Changes in vision-related quality of life will be assessed using the Impact of Visual Impairment for Children questionnaire. Scores will be reported on a logit scale. Higher scores indicate better vision-related quality of life.
Measured: Baseline before intervention; after 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.
Change in Social Participation
Changes in social participation will be assessed using the Child and Adolescent Scale of Participation. Scores range from 0 to 100, with higher scores indicating greater age-expected participation and therefore better social participation. The questionnaire will be completed using participant self-report and parent proxy-report versions, where applicable.
Measured: Baseline before intervention; after 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Jul 2026
- Study start1 Jan 2027 (estimated)
- Primary completion31 Jul 2027 (estimated)
- Study completion31 Aug 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (9)Papers the sponsor has linked to this study.
- Other trials for Visual ImpairmentStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 20 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Università degli Studi di Trento
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07703150
- Sponsor's protocol ID
- 26/2026
- Acronym
- VIPPSTAR_UNITN
- Status last verified
- Jun 2026
- First submitted
- 29 Jun 2026
- Last updated
- 14 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Wagner MO, Haibach PS, Lieberman LJ. Gross motor skill performance in children with and without visual impairments--research to practice. Res Dev Disabil. 2013 Oct;34(10):3246-52. doi: 10.1016/j.ridd.2013.06.030. Epub 2013 Jul 25.
PubMed 23891733Rogge AK, Hamacher D, Cappagli G, Kuhne L, Hotting K, Zech A, Gori M, Roder B. Balance, gait, and navigation performance are related to physical exercise in blind and visually impaired children and adolescents. Exp Brain Res. 2021 Apr;239(4):1111-1123. doi: 10.1007/s00221-021-06038-3. Epub 2021 Feb 7.
PubMed 33550429Lanza M, Incagli F, Ceccato C, Reffo ME, Mercuriali E, Parmeggiani F, Pagliano E, Saletti V, Leonardi M, Suppiej A, Dollfus H, LeBreton D, Finger RP, Leroy BP, Zemaitiene R, Nowomiejska K, Guastafierro E. Quality of life, functioning and participation of children and adolescents with visual impairment: A scoping review. Res Dev Disabil. 2024 Aug;151:104772. doi: 10.1016/j.ridd.2024.104772. Epub 2024 Jun 12.
PubMed 38870675Haegele JA, Porretta D. Physical activity and school-age individuals with visual impairments: a literature review. Adapt Phys Activ Q. 2015 Jan;32(1):68-82. doi: 10.1123/apaq.2013-0110.
PubMed 25544721Gori M, Cappagli G, Tonelli A, Baud-Bovy G, Finocchietti S. Devices for visually impaired people: High technological devices with low user acceptance and no adaptability for children. Neurosci Biobehav Rev. 2016 Oct;69:79-88. doi: 10.1016/j.neubiorev.2016.06.043. Epub 2016 Jul 30.
PubMed 27484870Furtado OL, Allums-Featherston K, Lieberman LJ, Gutierrez GL. Physical activity interventions for children and youth with visual impairments. Adapt Phys Activ Q. 2015 Apr;32(2):156-76. doi: 10.1123/APAQ.2014-0164.
PubMed 25799595Elsman EBM, Koel M, van Nispen RMA, van Rens GHMB. Quality of Life and Participation of Children With Visual Impairment: Comparison With Population Reference Scores. Invest Ophthalmol Vis Sci. 2021 Jun 1;62(7):14. doi: 10.1167/iovs.62.7.14.
PubMed 34115092Bakke HA, Cavalcante WA, de Oliveira IS, Sarinho SW, Cattuzzo MT. Assessment of Motor Skills in Children With Visual Impairment: A Systematic and Integrative Review. Clin Med Insights Pediatr. 2019 May 6;13:1179556519838287. doi: 10.1177/1179556519838287. eCollection 2019.
PubMed 31105435Alcaraz-Rodriguez V, Medina-Rebollo D, Munoz-Llerena A, Fernandez-Gavira J. Influence of Physical Activity and Sport on the Inclusion of People with Visual Impairment: A Systematic Review. Int J Environ Res Public Health. 2021 Dec 31;19(1):443. doi: 10.3390/ijerph19010443.
PubMed 35010704
Study at a glance
From the registry record, last updated by the sponsor on 14 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Promoting the Psychophysical Well-Being of Children and Adolescents With Visual Impairment
- ClinicalTrials.gov ID
- NCT07703150
- Acronym / sponsor ID
- VIPPSTAR_UNITN / 26/2026
- Keywords
- Physical Activity, Visual Impairment, Psychophysical Well-being, Physiological Monitoring, Social Inclusion
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 20 participants (estimated)
- Lead sponsor
- Università degli Studi di TrentoUniversity, hospital or other
- Study start
- 1 Jan 2027 (estimated)
- Primary completion
- 31 Jul 2027 (estimated)
- Study completion
- 31 Aug 2028 (estimated)
- First posted
- 14 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Visual impairment (VI) has significant implications not only for visual functioning, but also for the motor development, psychological well-being, and social participation of children and adolescents. Despite the fundamental role of physical activity in promoting health, autonomy, and quality of life, young people with VI still participate to a limited extent in structured physical activity programmes, owing to the lack of adapted interventions supported by robust scientific evidence. The European VIPPSTAR project (Horizon Europe 2024), conducted at the University of Trento, aims to address this gap through the development and validation of an integrated system of educational and rehabilitation interventions designed to promote the motor, physiological, and psychosocial competences of children and adolescents with VI.
This study marks the transition from the validation of the exercise battery in a controlled setting, carried out during the first phase of the VIPPSTAR project, to its implementation in participants' everyday environments. The aim is to assess its effectiveness, sustainability, and impact on psychophysical and relational well-being.
The study has a longitudinal, non-profit experimental design and will involve 20 children and adolescents with VI aged 10-17 years (50% female and 50% male), recruited through lower- and upper-secondary schools in the Autonomous Province of Trento participating in the project.
The intervention programme lasts 12 weeks and is divided into two blocks. During Block 1 (8 weeks), participants will complete the motor exercise battery twice weekly in the school setting, under the supervision of Abilnova educators. Sessions will take place twice a week, last approximately 45-60 minutes, and will be accompanied by fortnightly group meetings with classmates aimed at promoting social inclusion. During Block 2 (4 weeks), participants will perform the exercises at home, with the aim of consolidating the skills acquired and promoting autonomy in carrying out physical activity exercises, while continuing the fortnightly peer sessions at school.
The effectiveness of the programme will be evaluated using a pre-post design (T0-T1), with an intermediate assessment at the end of Block 1 (T0.5). An integrated assessment system will be used, including ComfTech® wearable devices for continuous monitoring of physiological parameters, such as heart rate, respiratory rate, body temperature, SpO₂, and ECG; video systems for the assessment of motor and postural performance; standardised questionnaires assessing quality of life and social participation; and structured observation grids during peer sessions. Data will be transmitted to the AVATAR system, a conversational system developed within the project, which processes physiological and kinematic information in real time. AVATAR does not operate autonomously and does not make medical decisions.
The results will contribute to validating an adapted, sustainable, and transferable exercise battery, laying the foundations for large-scale applications in clinical, educational, and rehabilitation settings, with potentially significant benefits for the quality of life and autonomy of young people with VI.
Study design
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Adapted Physical Activity Programme | Experimental | Behavioral: Adapted Physical Activity ProgrammeVI participants will receive a 12-week adapted physical activity programme. During the first 8 weeks, they will attend two supervised school-based exercise sessions per week (approximately 45-60 minutes each), alongside fortnightly peer-group sessions to promote social inclusion. During the final 4 weeks, participants will perform the exercises at home to consolidate acquired skills and support autonomy, while continuing fortnightly peer sessions at school. |
Who may qualify
- Ages
- 10 to 17 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (3 listed)
- Aged 10 to 17 years.
- Diagnosis of Visual Impairment (VI), defined as a congenital or acquired impairment of visual functioning that cannot be corrected solely through the use of glasses or contact lenses.
- Ability to participate in the exercise protocol, with adapted instructions or support where necessary.
Key exclusion criteria (3 listed)
- Presence of severe neurological, orthopaedic, or cardiac conditions that contraindicate moderate physical exercise.
- Current pregnancy.
- Conditions preventing the safe use of wearable devices, such as severe skin allergies or incompatible medical devices.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Adapted Physical Activity ProgrammeA 12-week adapted physical activity programme for children and adolescents with VI. During the first 8 weeks, participants will complete two supervised school-based exercise sessions per week, each lasting approximately 45-60 minutes, under the supervision of trained Abilnova educators. Fortnightly peer-group sessions with classmates will also be conducted to promote social inclusion. During the final 4 weeks, participants will perform the exercise programme at home to consolidate acquired motor skills and foster autonomy, while continuing the fortnightly peer sessions at school. The programme includes adapted motor, postural, and physical activity exercises tailored to participants' functional abilities. | Behavioural | Adapted Physical Activity Programme |
Primary outcome
Feasibility of the Adapted Physical Activity Programme
Time frame: Baseline before intervention; after 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.
Feasibility will be assessed through session completion rates across the school-based and home-based intervention blocks and adherence to planned procedures. Feasibility indicators will be reported as percentages, with higher percentages indicating greater feasibility of the programme.
Acceptability of the Adapted Physical Activity Programme
Time frame: After 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.
Acceptability will be assessed through the participant-rated acceptability of the programme using a 5-point Likert scale administered via the AVATAR system. Acceptability scores range from 1 to 5, with higher scores indicating greater acceptability of the programme.
Change in Movement Amplitude
Time frame: Baseline before intervention; after 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.
Changes in movement amplitude will be assessed using video-based analysis during the adapted exercise battery. Movement amplitude will be quantified as the range of motion of selected body segments during predefined motor tasks.
Change in Movement Execution Speed
Time frame: Baseline before intervention; after 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.
Changes in movement execution speed will be assessed using video-based analysis during the adapted exercise battery. Execution speed will be quantified as the time required to complete predefined motor tasks.
Change in Postural Stability
Time frame: Baseline before intervention; after 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.
Changes in postural stability will be assessed using video-based analysis during the adapted exercise battery. Postural stability will be quantified through indicators of balance control during predefined standing and movement tasks.
Change in Heart Rate
Time frame: Baseline before intervention; after 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.
Changes in heart rate will be assessed through real-time monitoring with ComfTech® wearable devices. Heart rate will be reported in beats per minute.
Change in Respiratory Rate
Time frame: Baseline before intervention; after 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.
Changes in respiratory rate will be assessed through real-time monitoring with ComfTech® wearable devices. Respiratory rate will be reported in breaths per minute.
Change in Peripheral Oxygen Saturation
Time frame: Baseline before intervention; after 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.
Changes in peripheral oxygen saturation will be assessed through real-time monitoring with ComfTech® wearable devices. Peripheral oxygen saturation will be reported as the percentage of oxygen-saturated hemoglobin in the blood.
Change in Body Temperature
Time frame: Baseline before intervention; after 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.
Changes in body temperature will be assessed through real-time monitoring with ComfTech® wearable devices. Body temperature will be reported in degrees Celsius.
Change in Electrocardiographic Parameters
Time frame: Baseline before intervention; after 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.
Changes in electrocardiographic parameters will be assessed through real-time monitoring with ComfTech® wearable devices. Electrocardiographic data will be used to derive cardiac rhythm-related parameters during the adapted exercise battery.
Change in Pediatric Quality of Life
Time frame: Baseline before intervention; after 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.
Changes in pediatric quality of life will be assessed using the Pediatric Quality of Life Inventory Version 4.0. Scores range from 0 to 100, with higher scores indicating better health-related quality of life. The questionnaire will be completed using participant self-report and parent proxy-report versions, where applicable.
Change in Vision-Related Quality of Life
Time frame: Baseline before intervention; after 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.
Changes in vision-related quality of life will be assessed using the Impact of Visual Impairment for Children questionnaire. Scores will be reported on a logit scale. Higher scores indicate better vision-related quality of life.
Change in Social Participation
Time frame: Baseline before intervention; after 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.
Changes in social participation will be assessed using the Child and Adolescent Scale of Participation. Scores range from 0 to 100, with higher scores indicating greater age-expected participation and therefore better social participation. The questionnaire will be completed using participant self-report and parent proxy-report versions, where applicable.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Jul 2026.
- Results publication: PubMed 23891733Wagner MO, Haibach PS, Lieberman LJ. Gross motor skill performance in children with and without visual impairments--research to practice. Res Dev Disabil. 2013 Oct;34(10):3246-52. doi: 10.1016/j.ridd.2013.06.030. Epub 2013 Jul 25.
- Results publication: PubMed 33550429Rogge AK, Hamacher D, Cappagli G, Kuhne L, Hotting K, Zech A, Gori M, Roder B. Balance, gait, and navigation performance are related to physical exercise in blind and visually impaired children and adolescents. Exp Brain Res. 2021 Apr;239(4):1111-1123. doi: 10.1007/s00221-021-06038-3. Epub 2021 Feb 7.
- Results publication: PubMed 38870675Lanza M, Incagli F, Ceccato C, Reffo ME, Mercuriali E, Parmeggiani F, Pagliano E, Saletti V, Leonardi M, Suppiej A, Dollfus H, LeBreton D, Finger RP, Leroy BP, Zemaitiene R, Nowomiejska K, Guastafierro E. Quality of life, functioning and participation of children and adolescents with visual impairment: A scoping review. Res Dev Disabil. 2024 Aug;151:104772. doi: 10.1016/j.ridd.2024.104772. Epub 2024 Jun 12.
- Results publication: PubMed 25544721Haegele JA, Porretta D. Physical activity and school-age individuals with visual impairments: a literature review. Adapt Phys Activ Q. 2015 Jan;32(1):68-82. doi: 10.1123/apaq.2013-0110.
- Results publication: PubMed 27484870Gori M, Cappagli G, Tonelli A, Baud-Bovy G, Finocchietti S. Devices for visually impaired people: High technological devices with low user acceptance and no adaptability for children. Neurosci Biobehav Rev. 2016 Oct;69:79-88. doi: 10.1016/j.neubiorev.2016.06.043. Epub 2016 Jul 30.
- Results publication: PubMed 25799595Furtado OL, Allums-Featherston K, Lieberman LJ, Gutierrez GL. Physical activity interventions for children and youth with visual impairments. Adapt Phys Activ Q. 2015 Apr;32(2):156-76. doi: 10.1123/APAQ.2014-0164.
- Results publication: PubMed 34115092Elsman EBM, Koel M, van Nispen RMA, van Rens GHMB. Quality of Life and Participation of Children With Visual Impairment: Comparison With Population Reference Scores. Invest Ophthalmol Vis Sci. 2021 Jun 1;62(7):14. doi: 10.1167/iovs.62.7.14.
- Results publication: PubMed 31105435Bakke HA, Cavalcante WA, de Oliveira IS, Sarinho SW, Cattuzzo MT. Assessment of Motor Skills in Children With Visual Impairment: A Systematic and Integrative Review. Clin Med Insights Pediatr. 2019 May 6;13:1179556519838287. doi: 10.1177/1179556519838287. eCollection 2019.
- Results publication: PubMed 35010704Alcaraz-Rodriguez V, Medina-Rebollo D, Munoz-Llerena A, Fernandez-Gavira J. Influence of Physical Activity and Sport on the Inclusion of People with Visual Impairment: A Systematic Review. Int J Environ Res Public Health. 2021 Dec 31;19(1):443. doi: 10.3390/ijerph19010443.
Related trials for Visual Impairment
Active, not recruiting
Improving Visual Field Deficits With Noninvasive Brain Stimulation
Visual Field Defect, Peripheral, Stroke
Recruiting
Implementing AI-based Glaucoma Screening Within Federally Qualified Health Centers
Glaucoma, Ocular Hypertension
Recruiting
Brain Stimulation Effects on Orientation and Mobility Skills in Adults With Vision Impairment
Retinitis Pigmentosa (RP), Rod Cone Dystrophy
Not yet recruiting
NEURO-COGS: Neurometabolic Mechanisms of Cognitive Training in Schizophrenia
Schizophrenia, Schizoaffective Disorder
RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO
Diabetic Macular Edema (DME)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Micol Gemignani, PhD contact
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Adapted Physical Activity Programme in people with Visual Impairment and Cerebral Visual Impairment, run by Università degli Studi di Trento at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 14 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Paola Venuti, PhD (+39 0464 808451, paola.venuti@unitn.it), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Feasibility of the Adapted Physical Activity Programme (time frame: Baseline before intervention; after 8 weeks of intervention, at the end of Block 1; immediately after the intervention, up to 12 weeks.). The study lists 13 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07703150, which also lists 9 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jul 2026.